Pain Management After Elective Shoulder Surgery
Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1120
- Austrian Workers Compensation Board Trauma Center Vienna Meidling
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all patients undergoing elective shoulder surgery with a single-shot interscalene plexus brachialis block in addition to general anesthesia
- patients aged 18-99 years
- patients being capable of giving an informed consent to participation in this study
Exclusion Criteria:
- patients aged below 18 years
- patients with decompensated liver, heart or renal insufficiency
- patients with any kind of lung disease
- patients with a chronic pain syndrome
- patients with a previous pain medication with more than 3 drugs over more than 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Hydromorphone
Hydromorphone Hcl 4 milligram (mg) Tab 2 times after surgery as basic medication.
Hydromorphone Hcl 2.6mg maximum 2 per 24h when numeric rating scale (NRS) > 5.
|
Hydal retard 4Mg Tab 2 times after surgery as basic medication.
Hydal retard 2.6Mg maximum 2 per 24h when NRS > 5.
Other Names:
|
|
Active Comparator: Piritramide
Piritramide 15mg s.c. 2 times after surgery as basic medication.
Piritramide 7.5mg s.c.
maximum 2 per 24h when numeric rating scale (NRS) > 5.
|
Dipidolor 15mg s.c. 2 times after surgery as basic medication.
Dipidolor 7.5mg s.c.
maximum 2 per 24h when NRS > 5.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain management after elective shoulder surgery
Time Frame: 6 months
|
Comparison of hydromorphone versus piritramide using the numeric rating scale (NRS; range 0 - 10 points; level 0 representing no pain; level 10 representing the highest pain level)
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Heinz Steltzer, MD, Prof., Trauma Center Vienna Meidling
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 5/18-Anesthesiology
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.